Polypid Ltd Quick Ratio (PYPD) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Polypid Ltd  (NASDAQ: PYPD)

Polypid Ltd's Quick Ratio

PYPD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 1.93 below Polypid Ltd's average Quick Ratio.

Within Medical Equipment & Supplies industry 96 other companies have achieved higher Quick Ratio than Polypid Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 0 to 1490.

Explain Quick Ratio?
How much Cash & cash equivalents PYPD´s has?
What are PYPD´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PYPD Quick Ratio (Dec 31 2025)
Q2		 (Jun 30 2025)
Q4		 (Dec 31 2024)
Q3		 0
Q2		 0
Q1
Y / Y Current Liabilities Change -27.91 % 2.76 % 73.08 % 138.1 % 23.95 %
Y / Y Cash & cash equivalent Change 38.02 % 89.48 % 181.85 % 0.21 % -27.43 %
Quick Ratio MRQ 1.93 2.45 1.32 1.33 1.01
PYPD's Total Ranking # 1490 # 0 # 1576 # #
Seq. Current Liabilities Change -43.86 % 0.98 % 1.77 % 24.95 % -19.97 %
Seq. Cash & cash equivalent Change -55.71 % 87.47 % 1.07 % 64.47 % -39.2 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 97
Healthcare Sector # 589
Overall Market # 1490


Quick Ratio Statistics
High Average Low
4.24 2.13 0.68
0   0




Financial Statements
Polypid Ltd's Current Liabilities $ 7 Millions Visit PYPD's Balance sheet
Polypid Ltd's Cash & cash equivalent $ 13 Millions Visit PYPD's Balance sheet
Source of PYPD's Sales Visit PYPD's Sales by Geography


Cumulative Polypid Ltd's Quick Ratio

PYPD's Quick Ratio for the trailling 12 Months

PYPD Quick Ratio

 (Dec 31 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Dec 31 2024)
12 Months		 0
12 Months		 0
12 Months
Y / Y Current Liabilities TTM Growth 28.98 % 44.92 % 66.05 % 46.76 % -19.01 %
Y / Y Cash & cash equivalent TTM Growth 60.05 % 41.3 % 20.64 % -19.4 % -15 %
Quick Ratio TTM 1.74 1.56 1.26 1.16 1.4
Total Ranking TTM # 3991 # 0 # 3656 # #
Seq. Current Liabilities TTM Growth -5.81 % 0.72 % 12.68 % 20.65 % 5.83 %
Seq. Cash & cash equivalent TTM Growth 5.12 % 24.73 % 21.98 % 0.07 % -7.2 %

Quick ratio ranking by company, industry and sector >> Back to PYPD Financial Strength Comparisons >> Go to Compare PYPD Quick Ratio to its Competitors

On the trailing twelve months basis PYPD Cash & cash equivalent grew by 38.02 % in Q4 2025 year on year, while Current Liabilities plummeted to $7 millions, this led to increase in in Polypid Ltd's Quick Ratio to 1.74, above PYPD average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Polypid Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 0 to 3991.

Explain Quick Ratio?
How much Cash & cash equivalents PYPD´s has?
What are PYPD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 214
Healthcare Sector # 987
Within the Market # 3991


trailing twelve months Quick Ratio Statistics
High Average Low
1.47 1.34 1.22
(Dec 31 2022)   (Dec 31 2021)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Inspiremd Inc   5.06 $ 54.211  Millions$ 10.712  Millions
Perspective Therapeutics Inc   5.05 $ 144.737  Millions$ 28.679  Millions
Iradimed Corporation  5.03 $ 51.159  Millions$ 10.180  Millions
Collplant Biotechnologies Ltd  5.00 $ 5.950  Millions$ 1.191  Millions
Soleno Therapeutics Inc  4.98 $ 305.472  Millions$ 61.363  Millions
Heartflow Inc   4.85 $ 176.786  Millions$ 36.448  Millions
Sensus Healthcare Inc   4.68 $ 22.083  Millions$ 4.722  Millions
Orasure Technologies Inc  4.64 $ 199.278  Millions$ 42.947  Millions
Outset Medical Inc   4.49 $ 168.946  Millions$ 37.630  Millions
Irhythm Holdings Inc   4.46 $ 583.763  Millions$ 131.003  Millions
Omada Health Inc   4.38 $ 222.036  Millions$ 50.668  Millions
Procept Biorobotics Corporation  4.35 $ 286.503  Millions$ 65.795  Millions
Clearpoint Neuro Inc   4.27 $ 45.923  Millions$ 10.765  Millions
Nexalin Technology Inc   4.20 $ 3.723  Millions$ 0.887  Millions
Alpha Pro Tech Ltd   4.19 $ 16.988  Millions$ 4.058  Millions
Vicarious Surgical Inc  3.96 $ 9.792  Millions$ 2.475  Millions
Icecure Medical Ltd  3.90 $ 8.897  Millions$ 2.280  Millions
Regentis Biomaterials Ltd   3.89 $ 7.378  Millions$ 1.895  Millions
Biolife Solutions Inc   3.87 $ 88.927  Millions$ 22.979  Millions
Solana Company  3.85 $ 7.282  Millions$ 1.890  Millions
Anika Therapeutics Inc   3.71 $ 81.171  Millions$ 21.908  Millions
Novocure Limited  3.66 $ 447.674  Millions$ 122.231  Millions
Pulmonx Corporation  3.48 $ 69.751  Millions$ 20.058  Millions
Inspira Technologies Oxy B H N Ltd  3.44 $ 6.416  Millions$ 1.864  Millions
Neuropace Inc   3.43 $ 61.058  Millions$ 17.814  Millions
Co diagnostics Inc   3.36 $ 11.885  Millions$ 3.540  Millions
Mobia Medical Inc   3.29 $ 33.587  Millions$ 10.206  Millions
Strata Critical Medical Inc   3.21 $ 61.495  Millions$ 19.142  Millions
Inspire Medical Systems inc   3.21 $ 308.268  Millions$ 96.055  Millions
Seastar Medical Holding Corp  3.20 $ 11.980  Millions$ 3.742  Millions

Date modified: 2026-07-07T12:42:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.